Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes

被引:28
|
作者
Skovso, S. [1 ]
Damgaard, J. [2 ]
Fels, J. J. [2 ]
Olsen, G. S. [2 ]
Wolf, X. A. [2 ]
Rolin, B. [2 ]
Holst, J. J. [1 ]
机构
[1] Univ Copenhagen, Panum Inst, Endocrinol Res Sect, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
[2] Novo Nordisk A S, Diabet Res Unit, Malov, Denmark
关键词
BODY-FAT; ADIPOSE-TISSUE; RISK-FACTOR; NPH INSULIN; OBESITY; RECEPTOR; PARTICIPANTS; ADIPONECTIN; DETERMINANT; CHOLESTEROL;
D O I
10.1038/ijo.2015.92
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND/OBJECTIVES: Insulin therapy is required for many patients with the obesity-related disorder type 2 diabetes, but is also associated with weight gain. The specific location of adipose tissue location matters to cardiovascular disease (CVD) risk. We investigated effects of exogenous insulin on fat distribution in the high-fat/high-sucrose fed rat treated with streptozotocin (HF/HS-STZ) rat model of type 2 diabetes. We also examined effects of insulin therapy on circulating CVD markers, including adiponectin, triglycerides (TGs), total cholesterol and high-density lipoprotein. SUBJECTS/METHODS: Male SD rats were HF/HS fed for 5 weeks followed by STZ treatment to mimic the hallmarks of human obesity-associated insulin resistance followed by hyperglycemia. Magnetic resonance imaging and computed tomography were used to determine total fat, abdominal fat distribution and liver fat before and after insulin therapy in HF/HS-STZ rats. HbA1c%, TGs, cholesterol, high-density lipoprotein and adiponectin were analyzed by conventional methods adapted for rats. RESULTS: Insulin therapy lowered HbA1c (P<0.001), increased body weight (P<0.001), increased lean mass (P<0.001) and led to a near doubling of total fat mass (P<0.001), with the highest increase in subcutaneous adipose tissue as compared with visceral adipose tissue (P<0.001). No changes in liver fat were observed after insulin therapy, whereas plasma TG and cholesterol levels were decreased (P<0.001, P<0.01), while high-density lipoprotein (HDL) and adiponectin levels were elevated (P<0.01, P<0.001). CONCLUSIONS: Using the HF/HS-STZ rat as an animal model for type 2 diabetes, we find that insulin therapy modulates fat distribution. Specifically, our data show that insulin has a relatively positive effect on CVD-associated parameters, including abdominal fat distribution, lean body mass, adiponectin, TGs and HDL in HF/HS-STZ rats, despite a modest gain in weight.
引用
收藏
页码:1531 / 1538
页数:8
相关论文
共 50 条
  • [21] Dual amylin and calcitonin receptor agonist as an adjunct therapy to insulin prevents weight gain and improve glucose control in an STZ-induced type 1 diabetic rat model
    Melander, S. A.
    Larsen, A. T.
    Karsdal, M. A.
    Henriksen, K.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S348 - S348
  • [22] Insulin Treatment and Weight Gain in Type 2 Diabetes: Is Our Knowledge Complete?
    Ryan, Miriam
    Livingstone, M. Barbara E.
    Ritz, Patrick
    CURRENT NUTRITION & FOOD SCIENCE, 2006, 2 (01) : 51 - 58
  • [23] Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin
    Balkau, Beverley
    Home, Philip D.
    Vincent, Maya
    Marre, Michel
    Freemantle, Nick
    DIABETES CARE, 2014, 37 (08) : 2108 - 2113
  • [24] Insulin detemir causes less gain in body weight and relative fat mass than human insulin in the STZ rat for the same degree of glycemic control
    Fledelius, Christian
    Damgaard, Jesper
    Endahl, Lars
    Ribel, Ulla
    Sturis, Jeppe
    DIABETES, 2006, 55 : A470 - A470
  • [25] Prediction of excessive weight gain in insulin treated patients with type 2 diabetes
    Cichosz, Simon Lebech
    Lundby-Christensen, Louise
    Johansen, Mette D.
    Tarnow, Lise
    Almdal, Thomas Peter
    Hejlesen, Ole K.
    JOURNAL OF DIABETES, 2017, 9 (04) : 325 - 331
  • [26] Excessive weight gain and effects on lipids with intensive therapy of type 1 diabetes
    Freedland, ES
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (23): : 1991 - 1991
  • [27] Insulin-Stimulated Increase in Serum Leptin Levels Precedes and Correlates with Weight Gain during Insulin Therapy in Type 2 Diabetes
    Aas, Anne-Marie
    Hanssen, Kristian F.
    Berg, Jens Petter
    Thorsby, Per M.
    Birkeland, Kare I.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08): : 2900 - 2906
  • [28] Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients
    Hwang, You-Cheol
    Lee, Eun Young
    Lee, Won Jae
    Cha, Bong Soo
    Yoon, Kun-Ho
    Park, Kyong Soo
    Lee, Moon-Kyu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (04): : 479 - 487
  • [29] Insulin therapy does not cause subsequent weight gain in well-controlled type 2 diabetes: A 2 year analysis
    Huizinga, Mary Margaret
    Michon, Stephanie
    Shackleford, Laura
    Brown, Anne
    Wolff, Kathleen
    King, Elaine
    Gregory, Becky
    Davis, Dianne
    Gebretsadik, Tebeb
    Shintani, Ayumi
    Rothman, Russell
    Pichert, Jim
    Schlundt, David
    Elasy, Tom
    DIABETES, 2006, 55 : A394 - A394
  • [30] Insulin is associated with less weight gain in well-controlled type 2 diabetes
    Huizinga, Mary Margaret
    Niswender, Kevin
    Gebretsadik, Tebeb
    Rothman, Russell
    Shintani, Ayumi
    Elasy, Tom A.
    DIABETES, 2007, 56 : A8 - A8